| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 顾资然 | 中信证券 | 医药生物 | 61.99% | 62.02% | 48.97% | 66.67% | 6 | -1.79% | 2025-09-02 |
| 2 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 61.95% | 60.39% | 37.07% | 12.50% | 6 | -27.10% | 2025-05-27 |
| 3 | 韩世通 | 中信证券 | 医药生物 | 61.83% | 47.01% | 31.03% | -2.04% | 6 | -63.25% | 2025-09-10 |
| 4 | 夏禹 | 国联民生 | 医药生物 | 61.81% | 33.62% | 4.91% | 20.00% | 7 | -52.01% | 2025-11-13 |
| 5 | 夏禹 | 国联民生 | 医药生物 | 61.78% | 28.94% | 4.57% | 20.00% | 7 | -52.01% | 2025-10-31 |
| 6 | 韩世通 | 中信证券 | 医药生物 | 61.70% | 46.27% | 33.19% | -2.04% | 6 | -63.25% | 2025-09-11 |
| 7 | 韩世通 | 中信证券 | 医药生物 | 61.66% | 42.77% | 33.03% | -2.04% | 6 | -63.25% | 2025-09-17 |
| 8 | 王道 | 申万宏源 | 医药生物 | 61.65% | 55.70% | 55.03% | 33.33% | 4 | -42.73% | 2025-09-22 |
| 9 | 阳景 | 浦银国际证券 | 医药生物 | 61.51% | 32.14% | 30.07% | 100.00% | 4 | 0.00% | 2025-08-28 |
| 10 | 韩世通 | 中信证券 | 医药生物 | 61.46% | 23.83% | -0.64% | -2.04% | 3 | -63.25% | 2025-12-25 |
| 11 | 李安飞 | 广发证券 | 医药生物 | 61.45% | 50.94% | 34.92% | -2.86% | 1 | -56.96% | 2025-06-11 |
| 12 | 阳景 | 浦银国际证券 | 医药生物 | 61.28% | 30.71% | -2.52% | 100.00% | 4 | 0.00% | 2025-11-13 |
| 13 | 阳景 | 浦银国际证券 | 医药生物 | 61.26% | 29.20% | 24.59% | 100.00% | 3 | 0.00% | 2025-08-21 |
| 14 | 阳景 | 浦银国际证券 | 医药生物 | 61.08% | 55.43% | 30.72% | 100.00% | 3 | 0.00% | 2025-07-28 |
| 15 | 夏禹 | 国联民生 | 医药生物 | 61.08% | 44.31% | 5.10% | 20.00% | 7 | -52.01% | 2025-09-09 |
| 16 | 夏禹 | 国联民生 | 医药生物 | 61.05% | 33.00% | 3.97% | 20.00% | 7 | -52.01% | 2025-11-14 |
| 17 | 唐寅灏 | 中信证券 | 医药生物 | 61.00% | 2.14% | -8.70% | 85.71% | 2 | -8.47% | 2025-12-12 |
| 18 | 顾资然 | 中信证券 | 医药生物 | 60.92% | 57.22% | 48.46% | 66.67% | 6 | -1.79% | 2025-09-11 |
| 19 | 韩世通 | 中信证券 | 医药生物 | 60.86% | 47.33% | 34.23% | -2.04% | 6 | -63.25% | 2025-09-08 |
| 20 | 刘浩 | 华创证券 | 医药生物 | 60.74% | 62.42% | 38.66% | 29.41% | 2 | -47.33% | 2025-06-25 |